Morningstar Investor users sign in here.

Company Profile

  • Business description

    Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

  • Contact

    1500 District Avenue
    Burlington MA 01803
    USA

    T: +1 617 600-7373

    E: wboni@minervaneurosciences.com

    https://www.minervaneurosciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    9

Stocks News & Analysis

stocks

7 ASX and global picks for an income growth portfolio

An income portfolio should include both high yields and the potential for dividend growth. I’ve outlined 7 opportunities for investors.
stocks

Is Guzman y Gomez the next McDonald's?

Perhaps, but our analysts think its closest ASX peer offers far better value.
video

Top opportunities in the Aussie tech and AI space

Morningstar's Michael Malseed interviews First Sentier's Dawn Kanelleas and Maple-Brown Abbott's Phil Hudak. 

Markets

Index
Last price
Change
% Change
All Ordinaries 8,012.10 1.60 0.02%
CAC 40 7,632.21 62.01 0.82%
DAX 40 18,134.43 66.52 0.37%
Dow JONES (US) 38,834.86 56.76 0.15%
FTSE 100 8,236.43 31.32 0.38%
HKSE 18,335.32 95.07 -0.52%
NASDAQ 17,862.23 5.21 0.03%
Nikkei 225 38,633.02 62.26 0.16%
NZX 50 Index 11,771.81 100.62 0.86%
S&P 500 5,487.03 0.00 0.00%
S&P/ASX 200 7,769.40 0.30 -0.00%
SSE Composite Index 3,005.44 12.61 -0.42%

Market Movers

Name
Last price
Change
% Change
Red 5 Ltd RED 0.41 0.04 -7.87%
Telstra Group Ltd TLS 3.61 0.01 0.28%
Pilbara Minerals Ltd PLS 3.20 0.02 -0.62%
Imugene Ltd IMU 0.06 0.00 5.36%
Mirvac Group MGR 1.95 0.02 1.04%
PYC Therapeutics Ltd PYC 0.14 0.02 17.39%
Liontown Resources Ltd LTR 0.99 0.02 -1.50%
Resolute Mining Ltd RSG 0.52 0.02 3.00%
Beach Energy Ltd BPT 1.47 0.01 0.34%
Sayona Mining Ltd SYA 0.04 0.00 2.94%